SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-003468 to SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)

SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)
Date: April 6, 2023 · CIK: 0001851860 · Accession: 0000000000-23-003468

AI Filing Summary & Sentiment

File numbers found in text: 333-271052

Date
April 6, 2023
Author
Not clearly detected
Form
UPLOAD
Company
SMART FOR LIFE, INC. (SMFL) (CIK 0001851860)

Letter

United States securities and exchange commission logo April 6, 2023 Darren Minton Chief Executive Officer SMART FOR LIFE, INC. 990 S Rogers Circle, Suite 3 Boca Raton, FL 33487 Re:SMART FOR LIFE, INC. Registration Statement on Form S-3 Filed March 31, 2023 File No. 333-271052 Dear Darren Minton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Louis Bevilacqua

Show Raw Text
United States securities and exchange commission logo
April 6, 2023
Darren Minton
Chief Executive Officer
SMART FOR LIFE, INC.
990 S Rogers Circle, Suite 3
Boca Raton, FL 33487
Re:SMART FOR LIFE, INC.
Registration Statement on Form S-3
Filed March 31, 2023
File No. 333-271052
Dear Darren Minton:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Louis Bevilacqua